/ Press Release Details /

Tumor Ablation Market Size Worth USD 1.79 Billion By 2025 | CAGR: 10.9%

The global Tumor Ablation market is expected to grow at growth rate of 10.9% to reach USD 1.79 Billion by 2025.

Tumor ablation is a minimally invasive surgery which is majorly used to treat tumors present in liver, kidney, bone, and lungs. In tumor ablation procedure, tissues are cooled or heated to less than 40°C or more than 60°C using thermal energy source. This procedure is widely accepted among the patient population due to its high efficacy and success rate. For example, as per the various research studies, the success rate of complete small liver cancer through this process is more than 85%. This treatment is an ideal option for the patients who failed during chemotherapy and radiotherapy.

In addition, increasing prevalence of cancer augment the market growth to great extent. As per the World Health Organization (WHO), cancer has taken the life of 9.6 million people in 2018. Excellent growth has also been observed in the worldwide market due to the rising awareness regarding the benefits of tumor ablation products over surgical and other conventional techniques. Other factors such as aging population, technology advancements and favourable government initiatives are fuelling the demand for this technology worldwide. On contrary, high cost of the procedure coupled with low acceptance rate in developing regions hamper the market growth during the forecast period.

Key Takeaways

Industry is categorized into four types namely radiofrequency, cryoablation, microwave and others. Among which, cryoablation accounted for significant revenue share and is projected to grow with promising growth rate in future.
In terms of application, the market is divided into breast, liver, prostate, lung and other applications. Depending upon the market size, liver cancer is accounted for the highest revenue share of the global market.
Asia Pacific region is anticipated to growth with the fastest growth rate owing to the rising incidence of chronic disease conditions such as cancer in countries like China and India
Key players such as Misonix, Galil Medical, Covidien plc, HealthTronics, Boston Scientific, Medtronic, Neuwave Medical and SonaCare Medical are profiled.
This market has come up with numerous opportunities for vendors and is characterized by the participation of both local and multinational vendors

KEY BENEFITS OF THE REPORT:

The report presents a macro and micro-level outlook regarding the industry. Thus, it becomes easy for our clients to perceive the business landscape and take a glimpse of their own standing in it.
A thorough analysis of relevant statistical data to estimate the market paradigms
Exceptional understanding of region and country-specific markets. The report will answer some of the toughest questions regarding the market shares, sizes, forecasts segmentations, and growth specific to the countries.
Well-designed strategic framework analyzes the market movements including regional expansion, mergers & acquisitions, and new product developments

The scope of this report covers the market by its major segments, which include as follows:

Market Segmentation

MARKET, BY PRODUCT